RAD140 is usually a non-steroidal selective androgen receptor modulator, or SARM, which emerged from an internal drug discovery plan that began in 2005. RAD140 has shown potent anabolic exercise on muscle and bone in preclinical research and concluded 28-working day preclinical toxicology studies in both of those rats and monkeys. As a result of it